EVAR (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Up 0.03 (0.00%)
Data as of 03/29/17 4:00 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.

Lombard Medical, Inc. is a medical device company focused on the $1.7bn market for minimally invasive treatment of abdominal aortic aneurysms (AAAs). The Company has global regulatory approval for Aorfix™, an endovascular stent graft which has been specifically designed to treat patients with the broadest range of AAA anatomies, including aortic neck angulation up to 90 degrees. The Company has also achieved CE Mark for the Altura™ endograft system, an innovative ultra-low profile endovascular stent graft that offers a simple and predictable solution for the treatment of more standard AAA anatomies. Altura was launched in Europe in January 2016, with an international rollout planned for later in 2016.

Lombard Medical is based in Oxfordshire, UK, with its manufacturing and OUS administrative office in Oxfordshire, UK. Lombard Medical's shares trade on the NASDAQ Global Market under the symbol EVAR.

Recent News

02/07/17Lombard Medical Announces Successful Completion of First 15 Cases in Japan for IntelliFlex™ LP Delivery System for the Aorfix™ Endovascular Stent GraftPrinter Friendly Version
01/05/17Lombard Medical Announces Regulatory Approval in Japan for IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent GraftPrinter Friendly Version
12/19/16Lombard Medical and MicroPort Scientific Corporation Announce Strategic Partnership and Investment AgreementPrinter Friendly Version

More »

Upcoming Events

There are currently no events scheduled.

More »

International Site
About Us | Careers | Terms | Contact Us | Site Map